Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of quetiapine in methamphetamine dependency
IRCT20171106037290N1Phase 3Completed
- Sponsor
- Kashan University of Medical Sciences
- Start
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of quetiapine in methamphetamine use disorder (MUD), sponsored by Kashan University of Medical Sciences. Started Oct 2017; status: completed.
02
Drugs
quetiapine
03
Conditions
methamphetamine use disorder (MUD)
Beyond the preview
Go deeper on IRCT20171106037290N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20171106037290N1.